Scholars Central

Conference abstract

Comparative bioequivalence, safety and performance evaluation of novel matrix type oxybutynin transdermal patch

Authors: Achyut Khire, Pradeep Vavia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

O xybutynin is widely used anticholinergic compound for overactive bladder (OAB) syndrome. When administered orally, high concentrations of metabolite N-desethyl oxybutynin (DEO) elicits side effects like dry mouth, blurred vision and other cholinergic disturbances. Transdermal oxybutynin have an edge over bypassing hepatic metabolism and thereby reducing metabolite formation and related side effects. The aim of proposed research work was to carry out comparative bioequivalence, safety and performance evaluation of developed novel matrix type oxybutynin transdermal patch with marketed patch (3.9mg/ day) which was kept as reference formulation.. The test formulations contain different types of chemical permeation enhancer i.e. Oleic acid (fatty acid), Soluphor P (cosolvent), menthol (volatile oil) and dipropylene glycol (plasticizer). A single dose, randomized, crossover pharmacokinetic study was carried out on healthy rabbits for period of 96 hrs. Patch was applied on dorsal side of abdomen. Plasma concentrations of oxybutynin were monitored using validated gas chromatographic method. Skin irritation (erythema, edema), patch adherence and local application site skin reactions were assessed following patch removal. The ratio of C max , AUC 0-96 , and AUC 0-inf at 90% confidence interval was found to be 0.92, 1.1, 1.2 for oleic acid, 0.86, 1.03, 1.1 for Soluphor P, 1.1, 1.17, 1.3 for menthol and 0.96, 1.19, 1.34 for dipropylene glycol. Wilcoxon signed rank test was used to assess performance of all permeation enhancers. The pharmacokinetic result demonstrates the developed formulations are bioequivalent with reference formulation and also found to be non irritating as well as safe with good adhesion to skin

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Achyut Khire”
  • BylineArticles whose byline prints “Pradeep Vavia”